logo

Health News

Share SHARE
E-Cigarette-110916-lg.jpg

A new study shows that teens who "vape" e-cigarettes are more likely to move on to regular cigarettes. The survey was conducted over ten Los Angeles county schools. The study was published November 8 in the Journal of American Medical Association. Leading researcher Adam Leventhal cited that, "teens who vape frequently are more than twice as likely to start smoking on about a weekly basis."
More
A new controversial "three-parent baby" treatment may be available on the United Kingdoms National Health Service plan by next spring. The Daily Mail reports that "An independent panel of experts has cleared away remaining safety hurdles to recommend "cautious adoption" of mitochondrial replacement therapy (MRT) for devastating inherited diseases."
More
untreatable-gonorrhea-071017.jpg There is a growing concern among the medical experts on the spread of antibiotic resistant and untreatable gonorrhea. Merck (MRK) said that it has accepted the external Data Monitoring Committee recommendation to pause new enrollment on KEYNOTE-183 and KEYNOTE-185, two studies exploring KEYTRUDA treatment in combination with other therapies in the blood cancer multiple myeloma. The company noted that the pause is... A new study finds that men with sexist ideologies are more likely to suffer from psychological and mental health issues. The Washington Post reported on a study published November 21 in the Journal of Counseling Psychology. The report analyzes 78 case studies on masculinity and mental health between 2003 and 2013. The participants range from ages 12 to over 65. More
tomato-112116.jpg Women who engage in yo-yo dieting may face a greater risk of heart disease, such as coronary heart disease and sudden cardiac death, according to a new study. The study, presented at the American Heart Association's Scientific Sessions 2016, featured 158,063 postmenopausal women split into four categories: stable weight, steady gain, maintained weight loss, and weight cycling. President Obama has proposed a new rule that prevents the defunding of Planned Parenthood in some states for political reasons. The proposition would prevent states from withholding Title X federal family planning money from constituents for any reasons other than their provider's "ability to deliver services to program beneficiaries in an effective manner." Vacutainer-blood-bottles-102616.jpg A new Canadian study finds that when it comes to blood transfusions, fresher blood is not any better than older blood. Nancy Heddle is a professor emeritus of medicine at McMaster University, in Hamilton, Ontario. Heddle cites, "Our study provides strong evidence that transfusion of fresh blood does not improve patient outcomes, and this should reassure clinicians that fresher is not better." More
Dignicap-FDA-120915.jpg

FDA Expands Approved Use Of Cooling Cap



Nearly one and a half years after securing FDA clearance for use in breast cancer patients to reduce the severity of chemotherapy-induced hair loss, DigniCap scalp cooling system has scored yet another regulatory nod.
More

Drug Resistant Gonorrhea On The Rise



The number of drug resistant cases of gonorrhea have increased in the U.S. in recent years, according to a new study from researchers at the Centers for Disease Control and Prevention. The agency released an official statement earlier this week noting that "the future of current treatment options may be in jeopardy."
More
PTSD-120116.jpg

FDA Agrees To New Trials To Use Ecstasy As Relief For PTSD Patients



The Food and Drug Administration has given permission for large-scale, Phase 3 clinical trials of MDMA— a final step before the possible approval of ecstasy as a prescription drug to treat posttraumatic stress disorder. The New York Times uses the example of an American soldier, C.J. Hardin who served in both Iraq and Afghanistan. Hardin tried all available methods of treating PTSD.
More




Follow RTT
FDA Calendar
Event DateSymbolDrug NameEvent Name
10/12/17ACRXDSUVIA (NDA)FDA decision on DSUVIA for the treatment of patients with moderate-to-severe acute pain in a medically supervised setting
10/09/17MYLPegfilgrastim (BLA)FDA decision on Pegfilgrastim as a proposed biosimilar to Amgen's Neulasta
10/06/17FLXNZilretta (NDA)FDA decision on Zilretta for treatment of patients with osteoarthritis of the knee
10/01/17JAZZVYXEOS (NDA)FDA decision on VYXEOS for the treatment of acute myeloid leukemia
09/28/17PTCTTranslarna (NDA)FDA panel to review Translarna for the treatment of nonsense mutation Duchenne muscular dystrophy
09/25/17IPCIRexista (NDA under 505(b)(2))FDA decision on Rexista Rexista™, an abuse- and alcohol-resistant, controlled-release oral oxycodone formulation
More FDA Calendar Data

FDA Device Approval
No Records Found
More FDA Device Approval Data